Dependence on VBAS and a narrow product base
A large share of the business is tied to one neurosurgical access system, so adoption changes can move revenue materially.
- Scope
- Neurosurgical device sales
- Materiality
- high
Vycor Medical Inc
Vycor Medical Inc. is a U.S.-based medical device company focused on neurosurgical access systems and non-invasive vision rehabilitation therapies. Its business is organized around two operating units: Vycor Medical, which designs and markets the ViewSite Brain Access System for brain and spine procedures, and NovaVision, which offers computer-based therapy for patients with vision disorders caused by neurological injury.
5,0 %
83,8 %
−3,9 %
+17,2 %
0.12
0.08
| % | |
|---|---|
| Neurosurgical access devices | 75% Brain and spine surgery access and retraction systems, including VBAS. |
| Vision rehabilitation therapies | 25% Computer-based therapies for patients with vision disorders after brain injury. |
Vycor sells primarily to hospitals and surgical users that need specialized tools for neurosurgery, especially brain...
- Hospitals and surgical centersprimary
Buy VBAS and related neurosurgical tools for brain and spine procedures because they need specialized access systems.
- Neurosurgeons and operating teamsprimary
Use the access and retraction systems in procedures where precision and minimally invasive access matter.
- Vision rehabilitation patientssecondary
Use NovaVision therapies for vision loss caused by stroke or other brain injury.
- Healthcare distributors and partnerssecondary
Help commercialize NovaVision and expand international access to Vycor products.
Vycor is headquartered in the United States and manufactures its products and raw materials domestically...
- •United States is the main manufacturing base and largest sales market
- •Hospitals in the U.S. account for the majority of product demand
- •Exports go to Canada, Japan, the UK, and the EU
- •European sales depend on CE Marking and local market access
- •International territories matter for growth and diversification
Vycor’s strategy centers on expanding revenue through deeper U.S. penetration, broader international distribution, and...
01
Expand U.S. market penetrationshort-term
The domestic hospital market is the core commercial base for VBAS and related products.
02
Grow international distributionmedium-term
International markets diversify revenue and can scale the neurosurgical platform beyond the U.S.
03
Partner or monetize NovaVisionmedium-term
Partnerships can extend reach for a niche therapy platform without heavy direct commercialization spend.
04
Broaden the product portfoliolong-term
Complementary products can increase wallet share and leverage the existing distribution network.
Vycor depends on a small number of specialized products and on hospital purchasing cycles, so adoption or reimbursement...
Partner dependence for NovaVision
NovaVision’s reach relies on third parties with direct access to end users or digital-health capability.
- Scope
- Distribution and licensing
- Materiality
- high
Regulatory and quality compliance
Medical devices require ongoing certification, clearance, and quality-system compliance to sell and maintain market access.
- Scope
- FDA, CE Marking, ISO 13485
- Materiality
- high
International trade and tariff exposure
The company exports to Canada, Japan, the UK and the EU, so retaliatory tariffs or trade friction could reduce international demand.
- Scope
- Export markets
- Materiality
- medium
Supply chain and raw material disruption
Although products are manufactured in the U.S., raw material prices and supply availability can still be affected by global trade conditions.
- Scope
- Manufacturing inputs
- Materiality
- medium
Revenue recognition on product sales
Reported sales and gross profit
Customer credits and write-offs
Other income and net results
Discontinued operations
Below-the-line operating results
Estimates and judgments
Assets, liabilities, revenue, and expenses
Vyome Holdings, Inc
HIND · Pharmaceutical Preparations
SOLENO THERAPEUTICS INC
Pharmaceutical Preparations
Vystar Corp
VYST · Fabricated Rubber Products, NEC
Vystar Corp is a U.S.-based company built around two product families: Vytex natural rubber latex materials and RxAir UV-C air purification devices.
CYTOKINETICS INC
CYTK · Pharmaceutical Preparations
Cytokinetics is a U.S.-based specialty biopharmaceutical company built around muscle biology and the mechanics of contractility.
electroCore, Inc.
ECOR · Electromedical & Electrotherapeutic Apparatus
Vicarious Surgical Inc.
RBOT · Orthopedic, Prosthetic & Surgical Appliances & Supplies
: 29.4.2026